How to Plug the Skills Gap
June 30, 2021
Experts from the BIA got together to discuss how the UK’s biotechnology industry can capitalize on recent investment and post-COVID-19 public appreciation to attract and train more people
1 min read
In our cover feature, we examine pharma’s relationship with AI and how these platforms could transform R&D and the business landscape. Meanwhile in "In My View", experts share their perspectives on digitalization, the importance of choosing the right technologies for bioprocessing, and more. We ask members of our 2021 Power List what the industry can learn from COVID-19 in “Business”, and we also find out how the UK’s biotechnology sector is looking to plug a skills gap by attracting a wave of new professionals to the industry. When it comes to next generation technologies, Lorna Ewart from Emulate explains how organ-on-chip technologies can be used to accelerate clinical development. Finally, we sit down with G-CON’s Maik Jornitz who walks us through the most surprising changes he’s witnessed during his time in industry.
June 30, 2021
Experts from the BIA got together to discuss how the UK’s biotechnology industry can capitalize on recent investment and post-COVID-19 public appreciation to attract and train more people
1 min read
June 24, 2021
How do we mitigate the risks and costs of choosing inappropriate technologies for the short and long term?
1 min read
June 23, 2021
Could zinc finger therapy hold the key to treating Alzheimer’s disease?
1 min read
June 17, 2021
Has AI been a savior in the battle against COVID-19?
1 min read
June 16, 2021
What opportunities await pharma as it begins to redirect its focus away from the pandemic?
1 min read
June 15, 2021
Do pharma organizations have the right mindset when it comes to adopting and implementing AI more widely?
1 min read
June 14, 2021
COVID-19 vaccine rollout is a lottery, with some countries faring much better than others
1 min read
June 11, 2021
Gene therapy’s “single most remarkable achievement,” CARs for solid tumors and plenty of new collaborations… What’s new from the Cell + Gene Curator?
1 min read
June 10, 2021
How collaboration and innovation – bolstered during the COVID-19 pandemic – will guide the future of stem cell transplantation.
1 min read
June 9, 2021
Is waiving patents for COVID-19 vaccines the right step forward?
1 min read
June 8, 2021
AI opens up new opportunities in R&D – and also provides pharma companies with new ways to connect with patients for better outcomes
1 min read
June 7, 2021
Sitting Down With… Maik Jornitz, President and CEO of G-CON
1 min read
June 5, 2021
Could frozen microneedles change the way we deliver cell therapies?
1 min read
June 2, 2021
Inventory management tools, Internet of Things, automated replenishment, AI… there are myriad opportunities to use digital tech to improve lab efficiency
1 min read
June 1, 2021
Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement when it comes to effectiveness if not efficacy
1 min read
May 26, 2021
Driven by innovation and the desire to meet new treatment options, pharmaceutical companies worldwide are looking to accelerate time to market for their products. Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.
1 min read
April 14, 2021
Looking for human-relevant information on an early drug candidate? Organ-on-chip technology can offer new insights.
1 min read
False
False